Navigation Links
KindredBio Schedules Release of 2014 Second Quarter Financial Results and Provides Timeline for Release of CereKin Pivotal Study Data
Date:8/6/2014

in dogs, AtoKin™ (fexofenadine) for the treatment of atopic dermatitis in dogs, and SentiKin™ (flupirtine) for the treatment of post-operative pain in dogs and cats.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including, but not limited to, statements regarding our expectations about the trials, regulatory approval, manufacturing, distribution and commercialization of our current and future product candidates, and statements regarding our anticipated revenues, expenses, margins, profits and use of cash.

These forward-looking statements are based on our current expectations. These statements are not promises or guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause our actual results to be materially different from any future results expressed or implied by the forward-looking statements.  These risks include, but are not limited to, the following:  our limited operating history and expectations of losses for the foreseeable future; the absence of revenue from our product candidates for the foreseeable future; our potential inability to obtain any necessary additional financing; our substantial dependence on the success of our lead product candidates, which may not be successfully commercialized even if they are approved for marketing; the effect of competition; our potential inability to obtain regulatory approval for our existing or future product candidates; our dependence on third parties to conduct some of our development activities; our dependence upon third-party manufacturers for supplies of our product candidates; uncertainties regarding the outcomes of trials regarding our product candidates; our potentia
'/>"/>

SOURCE Kindred Biosciences, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Thoratec Schedules First Quarter Conference Call, Webcast
2. 3SBio Inc. Schedules Unaudited First Quarter 2012 Results
3. Heartware Schedules First Quarter Conference Call And Webcast
4. Ampio Pharmaceuticals Schedules 2012 Update Webcast
5. China Botanic Schedules Conference Call to Discuss Second Quarter Fiscal Year 2012 Results
6. Mylan Schedules Second Quarter 2012 Financial Results Conference Call and Live Webcast
7. Sinovac Schedules 2012 Annual Meeting of Shareholders
8. 3SBio Inc. Schedules Unaudited Second Quarter 2012 Results
9. Volcano Corporation Schedules Second Quarter Conference Call, Webcast
10. Thoratec Schedules Second Quarter Conference Call, Webcast
11. Bacterin International Holdings, Inc. Schedules Second Quarter 2012 Financial Earnings Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... YORK , Sept. 22, 2014 ... exclusive, global license agreement with Plasma Technologies LLC ... proprietary plasma fractionation process. Concurrently, the Company announced ... to strategically refocus and rebrand the company as ... a national listing for its common shares. ...
(Date:9/22/2014)... , Sept. 22, 2014 Research ... "Global and Chinese Diclofenac Industry Report 2014" report ... Chinese Diclofenac Industry Report 2014 is a professional and ... diclofenac industry with a focus on the Chinese situation. ... the industry including definitions, classifications, applications and industry chain ...
(Date:9/20/2014)... OTTAWA , Sept. 20, 2014 /CNW/ - The issue: ... voluntarily recalling all lots of its Mylan-Nitro Spray 0.4 mg/metered ... is part of the pump component. A ... delivery of nitroglycerin to the patient. This defect may lead ... fact they are unable to access it. Not receiving nitroglycerin ...
Breaking Medicine Technology:Access Pharmaceuticals Announces Exclusive Global Plasma Therapeutics License, New Management And New Corporate Name 2Access Pharmaceuticals Announces Exclusive Global Plasma Therapeutics License, New Management And New Corporate Name 3Access Pharmaceuticals Announces Exclusive Global Plasma Therapeutics License, New Management And New Corporate Name 4Access Pharmaceuticals Announces Exclusive Global Plasma Therapeutics License, New Management And New Corporate Name 5Access Pharmaceuticals Announces Exclusive Global Plasma Therapeutics License, New Management And New Corporate Name 6Global and Chinese Diclofenac Industry Report 2014 2Advisory - Mylan Pharmaceuticals recalling nitroglycerin spray due to defective pump 2
... Consumers who have Medicare can now access updated ... conditions and coverage options, thanks to the re-release ...   http://photos.prnewswire.com/prnh/20100615/NCOALOGO ) (Logo:   http://www.newscom.com/cgi-bin/prnh/20100615/NCOALOGO ... Council on Aging (NCOA), the site offers users ...
... Roche Molecular Diagnostics (SIX: RO, ROG; OTCQX: RHHBY) announced today ... the COBAS® AmpliPrep / COBAS® TaqMan® HBV Test v2.0 for ... a fully automated solution for the quantitative detection of hepatitis ... patients on HBV antiviral therapy.   "This new ...
Cached Medicine Technology:MyMedicareMatters Website Expands Coverage of Critical Medicare Information 2MyMedicareMatters Website Expands Coverage of Critical Medicare Information 3Roche Receives FDA Approval for Second-Generation Hepatitis B Viral Load Test 2Roche Receives FDA Approval for Second-Generation Hepatitis B Viral Load Test 3
(Date:9/22/2014)... Asians living in Canada have a higher rate of ... with while people, McMaster researchers have found. , ... Medical Association Journal (CMAJ Open) and may be ... fastest-growing ethnic groups in the country is the more ... comprising about three percent of the population. They include ...
(Date:9/22/2014)... researchers have published a pilot study showing the ... people with multiple sclerosis (MS). Improvements were ... and pain. "Development and effectiveness of a ... Description and outcomes" was epublished ahead of print ... of MS Care (doi: 10.7224/1537-2073.2013-045). The authors ...
(Date:9/22/2014)... -- Two new prescription devices approved by the U.S. ... for people with migraine headaches who don,t tolerate migraine ... device -- the Cefaly -- is designed to prevent ... is meant to be used when migraines first start, ... been looking for alternative migraine treatments. Because these devices ...
(Date:9/22/2014)... Severe weather can occur with little warning, so it’s ... of National Preparedness Month, Amica Insurance is offering the ... unexpected:, , Build an emergency supply kit. It ... gallon of water per person per day for at least 72 ... includes pets so your family knows what to do and where ...
(Date:9/22/2014)... September 22, 2014 The New York ... of Surgery at the Icahn School of Medicine at ... York Group for Plastic Surgery gives residents of New ... a team of world-renowned plastic surgeons performing innovative reconstructive ... Salzberg, MD, who led NYGPS, was named the Director ...
Breaking Medicine News(10 mins):Health News:Higher risk of heart disease for South Asians in Canada 2Health News:Noninvasive Devices May Help Migraines, FDA Says 2Health News:Amica Shares Tips for National Preparedness Month 2Health News:The New York Group for Plastic Surgery Joins Mount Sinai Doctors 2Health News:The New York Group for Plastic Surgery Joins Mount Sinai Doctors 3
... San Diego, CA, August 18, 2009 While video gaming ... adults, research shows that the average age of players in ... Disease Control and Prevention (CDC), Emory University and Andrews University ... from 19 to 90 in the Seattle-Tacoma area on health ...
... INDIANAPOLIS, Aug. 17 Eli Lilly and Company (NYSE: ... for the Eastern District of Michigan has granted a motion by ... ,826 patent, or method-of-use patent, for Gemzar((R)) (gemcitabine HCl for injection) ... no bearing on Gemzar,s compound patent, which remains valid until November ...
... , , MIAMI, Aug. 17 In the ... Make You Thin , writer John Cloud tells us that these days, the ... wasting their time. He says that "exercise, in other words, isn,t necessarily helping ... After reading this article, Marta Montenegro is on a ...
... , WASHINGTON, Aug. 17 Earlier this ... Abbey College, a Roman-Catholic institution, must provide insurance coverage for ... http://www.newscom.com/cgi-bin/prnh/20080930/FRCLOGO ) , , The ruling goes ... state law which provides for exemption to for religious entities. ...
... A new study shows that elderly patients who ... ulcer bleeding had a two-day shorter hospital stay and ... patients who did not receive endoscopy within the first ... Center in Cleveland, Ohio, note that unless specific contraindications ...
... benign, others might pose dangers, experts say , MONDAY, ... skin can "trap" large amounts of indoor ozone, then "spit" ... the skin and the lungs, new research suggests. , "They ... ozone and cause more irritation to the skin," explained one ...
Cached Medicine News:Health News:New study finds links between video-game playing and health risks in adults 2Health News:New study finds links between video-game playing and health risks in adults 3Health News:U.S. District Court Rules Against Lilly Regarding Gemzar Patent 2Health News:U.S. District Court Rules Against Lilly Regarding Gemzar Patent 3Health News:U.S. District Court Rules Against Lilly Regarding Gemzar Patent 4Health News:Editor-In-Chief of SOBeFiT Magazine, Marta Montenegro, Says Time Magazine's Article 'Why Exercise Won't Make You Thin' Sends the Wrong Message 2Health News:Editor-In-Chief of SOBeFiT Magazine, Marta Montenegro, Says Time Magazine's Article 'Why Exercise Won't Make You Thin' Sends the Wrong Message 3Health News:Editor-In-Chief of SOBeFiT Magazine, Marta Montenegro, Says Time Magazine's Article 'Why Exercise Won't Make You Thin' Sends the Wrong Message 4Health News:Family Research Council President Tony Perkins Asks: Is This What President Obama Means by 'Robust' Conscience Protections? 2Health News:Endoscopy within 24 hours shows better outcomes in elderly with peptic ulcer bleeding 2Health News:Endoscopy within 24 hours shows better outcomes in elderly with peptic ulcer bleeding 3Health News:Endoscopy within 24 hours shows better outcomes in elderly with peptic ulcer bleeding 4Health News:Toxins May Form When Skin, Indoor Ozone Meet 2Health News:Toxins May Form When Skin, Indoor Ozone Meet 3
... 3000 Plus Sectioning System provides a versatile ... or plant tissues. The 3000 employs ... without freezing or embedding. The creation ... destruction of enzyme activities, and other deleterious ...
... standard with a square vice mounting ... utilized for mounting specimens and placing ... The blocks are annodized black for ... reused. They are shipped three ...
Injector blades come ten to an injector and allow for the easy replacement of Vibratome cutting blades....
... includes everything from the care package ... Spare Fluorescent Bulb, additional Vibratome Feather ... and a Specimen Tray. ... 1/2" speciment mounts, replacement rotating mounts, ...
Medicine Products: